News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News Oral Anticoagulation Boosts Poststroke Outcomes in Patients With A-fib Todd Neale May 18, 2018
News Daily News Weighing of Female Sex in Stroke Risk Scores Needs Rethink in A-fib Todd Neale February 26, 2018
News Conference News ISC 2018 Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH? Todd Neale January 30, 2018
News Industry News New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment January 29, 2018
News Daily News NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin L.A. McKeown January 02, 2018
News Daily News Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation Todd Neale September 27, 2017
News Daily News ‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry Todd Neale May 17, 2017
News Daily News If You Don’t Take Your Stroke Meds, This App Will Tell on You Todd Neale April 18, 2017
News Daily News MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke Michael O'Riordan April 05, 2017
News Daily News Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics Todd Neale March 03, 2017
News Conference News ISC 2017 NOAC-Related Intracranial Hemorrhages May Not Be as Bad as Those Stemming From Warfarin Todd Neale March 01, 2017
News Conference News ISC 2017 Restarting Oral Anticoagulation After Intracerebral Hemorrhage Tied to Better Outcomes Todd Neale February 27, 2017
News Conference News AHA 2016 Misdosing NOACs Common in Everyday Practice, With Implications for Stroke and Bleeding Shelley Wood November 21, 2016
News Conference News AHA 2016 Errar la Dosis de NOAC en la Práctica Clínica Diaria es algo Habitual, lo cual tiene Implicaciones en Materia de ACV y Hemorragias Shelley Wood November 21, 2016
News Daily News FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm Michael O'Riordan October 11, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows Yael L. Maxwell August 10, 2016